Public Joint-Stock Company "Artgen biotech" (ABIO)

84 financial statements for Public Joint-Stock Company "Artgen biotech" (ABIO), 2009 to 2026 — 33 IFRS and 51 RSBU, 82 verified line by line against the issuer's own filing. Balance sheet, income statement and cash flow, as filed.

Statements held: 84
Verified: 82
Period covered: 2009–2026
IFRS: 33 · RSBU: 51